Can we rely on 18F-choline PET-CT in detection of lymphogenous metastases in prostate cancer patients with biochemical recurrence after radical treatment?

2018 ◽  
Vol 17 (14) ◽  
pp. e2778
Author(s):  
O. Evsiukova ◽  
V. Cherniaev ◽  
O. Khalmurzaev ◽  
A. Odzharova ◽  
M. Dolgushin ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Biochemical Recurrence ◽  
Radical Treatment ◽  
Choline Pet ◽  
Pet Ct

Diagnostic Accuracy of 18F Choline PET/CT using Time-of-Flight Reconstruction Algorithm in Prostate Cancer Patients With Biochemical Recurrence

2014 ◽  
Vol 39 (3) ◽  
pp. e197-e201 ◽  
Author(s):  
Daniel Hausmann ◽  
Leonardo K. Bittencourt ◽  
Ulrike I. Attenberger ◽  
Metin Sertdemir ◽  
Anja Weidner ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Diagnostic Accuracy ◽  
Cancer Patients ◽  
Biochemical Recurrence ◽  
Time Of Flight ◽  
Reconstruction Algorithm ◽  
Choline Pet ◽  
Pet Ct

18 F-Choline PET/CT scan in staging and biochemical recurrence in prostate cancer patients: Changes in classification and radiotherapy planning

2017 ◽  
Vol 36 (5) ◽  
pp. 292-297
Author(s):  
J. Cardona Arboniés ◽  
B. Rodríguez Alfonso ◽  
J. Mucientes Rasilla ◽  
C. Martínez Ballesteros ◽  
I. Zapata Paz ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Ct Scan ◽  
Cancer Patients ◽  
Biochemical Recurrence ◽  
Radiotherapy Planning ◽  
Choline Pet ◽  
Pet Ct ◽  
Pet Ct Scan

[11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy

2009 ◽  
Vol 27 (5) ◽  
pp. 619-625 ◽  
Author(s):  
Ludwig Rinnab ◽  
Joerg Simon ◽  
Richard E. Hautmann ◽  
M. V. Cronauer ◽  
Kathrin Hohl ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Cancer Patients ◽  
Biochemical Recurrence ◽  
Choline Pet ◽  
Pet Ct

11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT

2013 ◽  
Vol 41 (5) ◽  
pp. 878-886 ◽  
Author(s):  
Francesco Ceci ◽  
Paolo Castellucci ◽  
Tiziano Graziani ◽  
Riccardo Schiavina ◽  
Eugenio Brunocilla ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Biochemical Recurrence ◽  
Choline Pet ◽  
Pet Ct

Assessment of volumetric parameters derived from 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Berna Okudan ◽  
Nazim Coşkun ◽  
Bedri Seven ◽  
Merve Ağcioğlu Atalay ◽  
Aslihan Yildirim ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Biochemical Recurrence ◽  
Psma Pet ◽  
Pet Ct

PD32-08 CHOLINE PET/CT SCAN FOR THE DETECTION OF NODAL RELAPSES OF PROSTATE CANCER AFTER BIOCHEMICAL RECURRENCE: RESULTS FROM A MULTICENTRIC STUDY

2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Marco Oderda ◽  
Paolo Gontero ◽  
Guglielmo Melloni ◽  
Stefania Munegato ◽  
Marco Falcone ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Ct Scan ◽  
Biochemical Recurrence ◽  
Multicentric Study ◽  
Choline Pet ◽  
Pet Ct ◽  
Pet Ct Scan

scholarly journals Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact

Cancers ◽  
2021 ◽  
Vol 13 (19) ◽  
pp. 4982
Author(s):  
Carlos Artigas ◽  
Romain Diamand ◽  
Qaid Ahmed Shagera ◽  
Nicolas Plouznikoff ◽  
Fabrice Fokoue ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Cancer Patients ◽  
Predictive Factors ◽  
Clinical Management ◽  
Biochemical Recurrence ◽  
Oligometastatic Disease ◽  
Psma Pet ◽  
Pet Ct ◽  
Hormone Sensitive

Metastasis-directed therapy (MDT) in oligometastatic prostate cancer has the potential of delaying the start of androgen deprivation therapy (ADT) and disease progression. We aimed to analyze the efficacy of PSMA-PET/CT in detecting oligometastatic disease (OMD), to look for predictive factors of OMD, and to evaluate the impact of PSMA-PET/CT findings on clinical management. We retrospectively analyzed a homogeneous population of 196 hormone-sensitive prostate cancer patients (HSPC), considered potential candidates for MDT, with a PSMA-PET/CT performed at biochemical recurrence (BCR) after radical prostatectomy (RP). Multivariable logistic regression analysis was performed based on several clinico-pathological factors. Changes in clinical management before and after PSMA-PET/CT were analyzed. The OMD detection rate was 44% for a total positivity rate of 60%. PSMA-PET/CT positivity was independently related to PSA (OR (95%CI), p) (1.7 (1.3–2.3), p < 0.0001) and PSAdt (0.4 (0.2–0.8), p = 0.013), and OMD detection was independently related to PSA (1.6 (1.2–2.2), p = 0.001) and no previous salvage therapy (0.3 (0.1–0.9), p = 0.038). A treatment change was observed in 58% of patients, mostly to perform MDT after OMD detection (60% of changes). This study showed that PSMA-PET/CT is an excellent imaging technique to detect OMD early in HSPC patients with BCR after RP, changing therapeutic management mostly into MDT.

Sign in / Sign up

Export Citation Format

Share Document